XBIT
XBiotech Inc
NASDAQ: XBIT · HEALTHCARE · BIOTECHNOLOGY
$2.52
-0.79% today
Updated 2026-04-29
Market cap
$77.44M
P/E ratio
—
P/S ratio
12.23x
EPS (TTM)
$-1.49
Dividend yield
—
52W range
$2 – $4
Volume
0.0M
XBiotech Inc (XBIT) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $12.68M | $44.00M | $18.39M | $4.01M | $300000.00 | $0.00 | $0.00 |
| Revenue growth (YoY) | — | — | — | — | — | — | — | — | +247.0% | -58.2% | -78.2% | -92.5% | -100.0% | — |
| Cost of revenue | — | — | $0.00 | $699000.00 | $698000.00 | $0.00 | $2.43M | $2.36M | $34.55M | $5.82M | $651000.00 | $1.74M | $1.75M | $1.69M |
| Gross profit | — | — | $0.00 | $-699000.00 | $-698000.00 | $0.00 | $-2.43M | $-2.36M | $9.45M | $12.57M | $3.36M | $-1.74M | — | $-1.69M |
| Gross margin | — | — | — | — | — | — | — | -18.6% | 21.5% | 68.4% | 83.8% | -581.3% | — | — |
| R&D | $13.33M | $7.93M | $14.33M | $31.31M | $42.49M | $26.42M | $15.72M | $24.09M | $9.53M | $28.27M | $31.54M | $32.85M | $37.76M | $47.39M |
| SG&A | $1.83M | $1.99M | $7.45M | $6.20M | $10.28M | $7.63M | $5.27M | $7.14M | $18.20M | $9.39M | $6.30M | $4.66M | $4.71M | $8.29M |
| Operating income | $-15.16M | $-9.93M | $-21.78M | $-37.51M | $-52.76M | $-34.06M | $-20.99M | $-31.23M | $-18.28M | $-25.08M | $-34.49M | $-37.51M | $-42.47M | $-55.69M |
| Operating margin | — | — | — | — | — | — | — | -246.3% | -41.5% | -136.4% | -860.1% | -12503.3% | — | — |
| EBITDA | $-14.21M | $-9.14M | $-21.11M | $-36.81M | $-52.06M | $-33.13M | $-18.70M | $720.81M | $-16.04M | $-22.43M | $-31.88M | $-22.57M | $-36.01M | $-54.00M |
| EBITDA margin | — | — | — | — | — | — | — | 5684.2% | -36.5% | -122.0% | -794.9% | -7523.0% | — | — |
| EBIT | $-15.16M | $-9.93M | $-21.78M | $-37.51M | $-52.76M | $-34.61M | $-21.14M | $718.45M | $-18.28M | $-25.08M | $-34.49M | $-24.31M | $-37.76M | $-55.69M |
| Interest expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $748.80M | $8.95M | $1.09M | $902000.00 | $0.00 | $807000.00 | $88000.00 |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-15.16M | $-9.93M | $-21.72M | $-37.48M | $-52.76M | $-33.15M | $-21.14M | $668.63M | $-11.22M | $-17.41M | $-32.90M | $-24.56M | $-38.53M | $-45.54M |
| Net income growth (YoY) | — | +34.5% | -118.8% | -72.5% | -40.8% | +37.2% | +36.2% | +3263.2% | -101.7% | -55.2% | -88.9% | +25.4% | -56.9% | -18.2% |
| Profit margin | — | — | — | — | — | — | — | 5272.7% | -25.5% | -94.7% | -820.4% | -8185.7% | — | — |